Publications by authors named "F Ashtari"

Background: The plethora of troublesome signs and symptoms of multiple sclerosis (MS) reduces patients' quality of life (QOL) and coping skills. Face-to-face (F2F) education is effective and practical as it allows for more engagement and active learning. The use of mobile health technology to enhance health is now an excellent potential to establish a more efficient health system.

View Article and Find Full Text PDF

Objectives: It is estimated that up to 65 % of pwMS (people with multiple sclerosis) experience varying degrees of cognitive impairment, the most commonly affected domain being Information Processing Speed (IPS). As sleep disturbance is a predictor of detriments in IPS, the authors aimed to study the association between the severity of Restless Legs Syndrome (RLS) and Obstructive Sleep Apnea (OSA) symptoms with IPS in pwMS.

Methods: In a cross-sectional study, the authors enrolled people with relapsing-remitting and secondary progressive MS referred to the comprehensive MS center of Kashani Hospital in Isfahan, Iran.

View Article and Find Full Text PDF

Multiple sclerosis (MS) predominantly affects women of childbearing age, significantly impacting their quality of life (QOL). The diagnosis of MS can influence pregnancy intention, and the level of disability associated with MS may change before and after pregnancy. This study aims to analyze the reproductive characteristics of Iranian female patients with MS (PwMS) and their association with the Expanded Disability Status Scale (EDSS) and pregnancy tendency, providing valuable insights into disease progression and the development of tailored treatments.

View Article and Find Full Text PDF

Background: We aimed to explore the association between peripapillary retinal nerve fiber layer thickness (pRNFL), macular ganglion cell-inner plexiform layer (mGCIPL), and cognitive impairment (CI) in patients with neuromyelitis optica spectrum disorder (NMOSD).

Method: In this cross-sectional study, 38 (28 aquaporin-4 (AQP4) IgG-seropositive) NMOSD patients and 20 healthy controls (HC) underwent cognitive assessment using Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) battery. Spectral-domain optical coherence tomography (OCT) was performed for both eyes of all NMOSD patients.

View Article and Find Full Text PDF
Article Synopsis
  • - Multiple sclerosis is a serious condition, and the study compared the efficacy and safety of a biosimilar drug called Xacrel to the original drug, Ocrevus, in patients with Relapsing Multiple Sclerosis (RMS) over 96 weeks.
  • - The main goal was to see if both drugs had similar effects on reducing annual relapse rates (ARR) at 48 weeks, while also assessing other factors like disability progression, MRI results, and safety.
  • - Results showed that Xacrel was equivalent to Ocrevus in reducing ARR, with no significant differences in efficacy or safety observed during the trial, confirming Xacrel as a viable alternative to Ocrevus.
View Article and Find Full Text PDF